Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. Baldini C, Younan N, Castanon Alvarez E, Ammari S, et al. Eur J Cancer 2022;163:98-107.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Baldini C, Younan N, Castanon Alvarez E, Ammari S, et al. Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials. Eur J Cancer 2022;163:98-107.
PMID: 35063776